VA Seeks OMB Nod for Insurance Assignment Paperwork
Published Date: 8/31/2026
Notice
Summary
In compliance with the Paperwork Reduction Act (PRA) of 1995, this notice announces that the Veterans Benefits Administration, Department of Veterans Affairs, will submit the collection of information abstracted below to the Office of Management and Budget (OMB) for review and comment. The PRA submission describes the nature of the information collection and its expected cost and burden, and it includes the actual data collection instrument.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
New Form to Assign VA Life Benefits
If you are a beneficiary of VA Government Life Insurance, VA Form 29-538 will let you formally request assigning your portion of the policy's death benefits to another descendant of the insured, under 38 U.S.C. 1918. If the death benefit is paid in installments, the contingent beneficiary must sign. The agency estimates 10 respondents annually with an average 5-minute response time, and comments are due by September 30, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11973, Implementing Regulation for National Environmental Policy Act (NEPA): Environmental Effects of the Department of Veterans Affairs Actions
The Department of Veterans Affairs is updating how it checks the environmental impact of its projects to be faster, clearer, and more in line with new laws passed since 1989. This change affects VA staff and veterans by improving planning and making sure VA actions protect the environment while delivering care. The new rules start June 15, 2026, and the VA welcomes feedback until July 15, 2026.
2026-03940, Rescission of Interim Final Rule, Evaluative Rating: Impact of Medication
The VA is canceling a new rule about how medication affects disability ratings and going back to the old rules right away. This change affects veterans applying for benefits, making sure their claims are handled like before without confusion or delays. The switch happens immediately and won’t change any money owed but keeps things steady while legal questions get sorted out.
2025-21242, Extending Deadline for Debtor To Request a Waiver
The VA is giving veterans more time—up to one year instead of 180 days—to ask for a waiver on debts related to benefits. This change, effective January 26, 2026, helps reduce stress by giving veterans extra breathing room to handle their debt issues. It doesn’t cost veterans extra money but makes the process friendlier and fairer.
2025-18827, Extension of Program of Comprehensive Assistance for Family Caregivers Eligibility for Legacy Participants and Legacy Applicants
The VA is giving family caregivers of veterans more time to stay in their special support program by extending the deadline from 2025 to 2028. This means caregivers and veterans who joined the program earlier (the legacy group) can keep getting help for three more years. No changes to money or benefits, just extra time to enjoy the support they deserve!
2025-14687, Reproductive Health Services
The VA is planning to stop covering abortions and abortion counseling again, reversing a 2022 change. This affects veterans and their families who use VA and CHAMPVA health benefits. The change aims to focus VA services on what they consider essential care, with no new costs or timing details shared yet.
2026-17541, Agency Information Collection Activity Under OMB Review: CFM Stakeholder Feedback Survey
The Department of Veterans Affairs is updating its CFM Stakeholder Feedback Survey to better understand how project teams are doing on big construction and lease projects. This survey affects VA employees, Army Corps teams, and private contractors who work on these projects. They’re asking for comments by September 28, 2026, to help improve teamwork without adding extra costs or time burdens.
Previous / Next Documents
Previous: 2026-17717, Senior Executive Service Performance Review Board Membership
The Department of Transportation just announced the new team members for its Senior Executive Service Performance Review Boards. These folks will help review and rate top executives’ work, making sure leaders stay on track. This update affects senior leaders and keeps the review process fresh and fair, with no changes to pay or timing.
Next: 2026-17719, Authorization of Emergency Use for Three Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability
The Food and Drug Administration (FDA or the Agency) is announcing the issuance of three Emergency Use Authorizations (EUA or Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) for new animal products. FDA has issued one EUA for an animal product as requested by Zoetis Inc. for the prevention and treatment of infestations caused by New World screwworm (Cochliomyia hominivorax; NWS) larvae (myiasis) in dairy cattle, horses, swine, sheep, and deer. FDA has issued one EUA for an animal product as requested by Felix Pharmaceuticals Pvt. Ltd. for the treatment of infestations caused by NWS myiasis in dogs, puppies, cats, and kittens. FDA has issued one EUA for an animal product as requested by Alberta Vet Labs Ltd for the short-term prevention of infestations caused by NWS myiasis in horses. The Authorizations contain, among other things, conditions on the emergency use of the authorized products. The Authorizations follow the August 18, 2025, determination by the Secretary of Health and Human Services (HHS) that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of U.S. citizens living abroad and that involves NWS. On the basis of such determination, the Secretary of HHS declared on August 18, 2025, that circumstances exist justifying the authorization of emergency use of animal drugs to treat or prevent NWS myiasis in animals. The Authorizations, which include an explanation of the reasons for issuance, are reprinted in this document.